NASDAQ:EYEN
Eyenovia Inc. Stock News
$0.750
-0.0710 (-8.65%)
At Close: May 17, 2024
Eyenovia to Report Third Quarter 2021 Results on Thursday, November 11
04:05pm, Thursday, 04'th Nov 2021
Company to host an investor conference call and webcast at 5:00pm ET on that day Company to host an investor conference call and webcast at 5:00pm ET on that day
Eyenovia: Can You See Me Now?
01:24pm, Thursday, 21'st Oct 2021
A late-stage biotech company with three products in their pipeline.
Eyenovia (EYEN) Sees Hammer Chart Pattern: Time to Buy?
08:00am, Thursday, 30'th Sep 2021
Eyenovia (EYEN) has been struggling lately, but the selling pressure may be coming to an end soon.
5 Best Penny Stocks To Buy Right Now According To Insiders
10:53am, Wednesday, 25'th Aug 2021
5 Penny Stocks Insiders Are Buying Right Now The post 5 Best Penny Stocks To Buy Right Now According To Insiders appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Eyenovia (EYEN) Sees Hammer Chart Pattern: Time to Buy?
09:13am, Thursday, 19'th Aug 2021
Eyenovia (EYEN) has been struggling lately, but the selling pressure may be coming to an end soon.
Eyenovia's (EYEN) Management on Q2 2021 Results - Earnings Call Transcript
08:18pm, Wednesday, 11'th Aug 2021
Eyenovia's (EYEN) Management on Q2 2021 Results - Earnings Call Transcript
Eyenovia Reports Second Quarter 2021 Financial Results
04:05pm, Wednesday, 11'th Aug 2021
Announced positive topline data from its Phase 3 VISION-1 study evaluating MicroLine for the treatment of presbyopia
Eyenovia to Participate in Two Upcoming Investor Conferences
04:01pm, Wednesday, 07'th Jul 2021
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array p
Eyenovia: Recent MicroLine Data, October MydCombi PDUFA Date Bode Well For Value Creation
06:10am, Wednesday, 02'nd Jun 2021
Eyenovia is a specialty ophthalmic company that I have previously recommended. The company has three drugs in its pipeline - MydCombi, MicroLine, and MicroPine - all using Eyenovia's proprietary Optej
Eyenovia Stock Shoots Higher on Positive MicroLine Data in Late-Stage Presbyopia Study
11:18am, Tuesday, 25'th May 2021
Eyenovia Inc (NASDAQ: EYEN) has announced topline data from its VISION-1 Phase 3 study evaluating MicroLine, for the temporary improvement of near vision in adults with presbyopia. The results will
Eyenovia Announces Positive Topline Results from VISION-1 Phase 3 Clinical Study of MicroLine for the Treatment of Presbyopia
09:03am, Tuesday, 25'th May 2021
Primary endpoint was achieved with well-tolerated micro-array print (MAP™) safety profile
Eyenovia: Still A Great Long-Term Investment In Ophthalmology
12:43am, Friday, 21'st May 2021
Eyenovia: Still A Great Long-Term Investment In Ophthalmology
Eyenovia's (EYEN) CEO Sean Ianchulev on Q1 2021 Results - Earnings Call Transcript
10:35pm, Wednesday, 12'th May 2021
Eyenovia's (EYEN) CEO Sean Ianchulev on Q1 2021 Results - Earnings Call Transcript
Eyenovia Announces New $25 Million Credit Facility with Silicon Valley Bank
08:30am, Monday, 10'th May 2021
NEW YORK, May 10, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, to
Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q4 2020 Results - Earnings Call Transcript
10:50pm, Thursday, 25'th Mar 2021
Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q4 2020 Results - Earnings Call Transcript
